205 filings
8-K
NUWE
Nuwellis Inc
26 Jun 24
Nuwellis Announces Reverse Stock Split
9:19am
8-K
NUWE
Nuwellis Inc
10 Jun 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:15pm
8-K
NUWE
Nuwellis Inc
6 Jun 24
Nuwellis and DaVita Extend Supply and Collaboration Agreement Pilot Phase
9:15am
8-K
NUWE
Nuwellis Inc
29 May 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:33pm
8-K
NUWE
Nuwellis Inc
7 May 24
Nuwellis, Inc. Announces First Quarter 2024 Financial Results
11:02am
8-K
995ep5 0h
30 Apr 24
Nuwellis Announces Pricing of $2.7 Million Public Offering
6:25pm
8-K
hlce8
26 Mar 24
Other Events
5:00pm
8-K
5lf mqklrikf
6 Mar 24
Nuwellis, Inc. Announces Fourth Quarter and Full Year 2023 Financial Results
12:02pm
8-K
0qow u1foqydemm16rd
6 Feb 24
Other Events
9:07am
8-K/A
b8kh0b7iepym4 4pjub
9 Jan 24
Regulation FD Disclosure
5:30pm
8-K
ckgxjwos 4ir
8 Jan 24
Regulation FD Disclosure
9:24am
8-K
lzcda
13 Dec 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:05pm
8-K
aajt 3tr9rklvns
7 Nov 23
Nuwellis, Inc. Announces Third Quarter 2023 Financial Results
8:15am
8-K
gl50oy2x9 ob6k6czc
1 Nov 23
Nuwellis Announces Board of Directors Transition
4:15pm
8-K
25ioj3a3
17 Oct 23
Nuwellis Announces Pricing of $2.25 Million Public Offering of Series J Convertible Redeemable Preferred Stock and Warrants
4:30pm
8-K
grlnx3
10 Oct 23
Other Events
8:30am
8-K
5ioesu35lgqx4
18 Aug 23
Departure of Directors or Certain Officers
4:56pm
8-K
bibdodumh3
8 Aug 23
Nuwellis Announces Plan for Cfo Transition
8:25am
8-K
1mgm6y7lzb
8 Aug 23
Nuwellis, Inc. Announces Second Quarter 2023 Financial Results
8:15am
8-K
cbtgdbr6i9krt
20 Jun 23
Supply Agreement to Pilot Ultrafiltration Therapy Services Offering in Select Markets
6:55pm